These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy and tolerance of Algicon in patients with reflux oesophagitis. Lancaster Smith MJ, Miller JP, Whorwell PJ. Br J Clin Pract Suppl; 1989 Feb; 66():38-42; discussion 61-4. PubMed ID: 2511921 [No Abstract] [Full Text] [Related]
4. Effects of Algicon on the ultrastructure of the mucosa of subjects with reflux oesophagitis. Trabucchi E, Foschi D, Radaelli E, Callioni F, Montorsi W. Br J Clin Pract Suppl; 1989 Feb; 66():43-7; discussion 61-4. PubMed ID: 2511922 [No Abstract] [Full Text] [Related]
14. Oesophagitis and the role of antacid therapy. Rhodes J. Scand J Gastroenterol Suppl; 1982 Feb; 75():74-6. PubMed ID: 6959253 [No Abstract] [Full Text] [Related]
15. Sucralfate and alginate/antacid in reflux esophagitis. Laitinen S, Ståhlberg M, Kairaluoma MI, Kiviniemi H, Pääkkönen M, Lahtinen J, Poikolainen E, Aukee S. Scand J Gastroenterol; 1985 Mar; 20(2):229-32. PubMed ID: 2986275 [Abstract] [Full Text] [Related]
18. Comparison of a dimethicone/antacid (Asilone gel) with an alginate/antacid (Gaviscon liquid) in the management of reflux oesophagitis. Smart HL, Atkinson M. J R Soc Med; 1990 Sep; 83(9):554-6. PubMed ID: 2213800 [Abstract] [Full Text] [Related]
19. Endoscopically controlled trial of alginate and antacid in reflux oesophagitis. Scobie BA. Med J Aust; 1976 Apr 24; 1(17):627-8. PubMed ID: 778564 [Abstract] [Full Text] [Related]